Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.

Item
http://www.wikidata.org/entity/Q33559298
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection.Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis CPeginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial.A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney DiseasePeginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells.Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
P2860

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.

Item
http://www.wikidata.org/entity/Q33559298
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@ast
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@en
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@nl
type
label
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@ast
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@en
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@nl
prefLabel
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@ast
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@en
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@nl
P1433
P1476
P275
P2860
P304
P31
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932
P356
P1433
P1476
Nanomedicines in the treatment ...... ing use of peginterferon alfa.
@en
P275
P2860
P304
P31
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932